Filing Flows › Innospec (IOSP) › Q3 2026 › vs Q3 2025
Innospec (IOSP) Q3 2026 vs Q3 2025 (year over year)
Innospec's revenue rose $31.7M (+7%) from $442M in Q3 2025 to $474M in Q3 2026. Gross margin 27.3% against 26.4% (+0.9 pts).
Innospec, Q3 2026: revenue $474M (+7% year over year), operating margin 8.8%, net earnings $31.6M, operating cash flow $17.4M. The chart draws each line against Q3 2025, the increases inside each band.
Margins
| Q3 2026 | Q3 2025 | Change | |
|---|---|---|---|
| Gross margin | 27.3% | 26.4% | +0.9 pts |
| Operating margin | 8.8% | 1.3% | +7.5 pts |
| Net margin | 6.7% | 2.9% | +3.8 pts |
| Free cash flow margin | 0.3% | 5.6% | -5.3 pts |
Every line
| Line | Q3 2026 | Q3 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $474M | $442M | $31.7M | +7% |
| Gross profit | $129M | $117M | $12.4M | +11% |
| Cost of revenue | $344M | $325M | $19.3M | +6% |
| Operating profit | $41.7M | $5.9M | $35.8M | +607% |
| Operating expenses | $87.4M | $111M | −$23.4M | -21% |
| Pre-tax earnings | $42.6M | $11.3M | $31.3M | +277% |
| Net earnings | $31.6M | $12.7M | $18.9M | +149% |
| Income tax | $11.0M | −$1.4M | $12.4M | — |
| Depreciation & amortization | $9.6M | $12.2M | −$2.6M | -21% |
| Share-based compensation | $1.4M | $900K | $500K | +56% |
| Working capital & other | $25.2M | −$13.3M | $38.5M | — |
| Operating cash flow | $17.4M | $39.1M | −$21.7M | -55% |
| Free cash flow (OCF − capex) | $1.6M | $24.8M | −$23.2M | -94% |
| Capital expenditures | $15.8M | $14.3M | $1.5M | +10% |
Questions
How much did Innospec's revenue grow year over year in Q3 2026?
Innospec's revenue rose $31.7M (+7%) from $442M in Q3 2025 to $474M in Q3 2026. Gross margin 27.3% against 26.4% (+0.9 pts).